EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Comparing the Efficacy of Fosnetupitant, an NK1 Receptor Antagonist in CDDP-Based Regimens, with That of Fosaprepitant and Aprepitant: A Retrospective Observational Study

Hiroshi Inano, Yoshihito Morimoto, Kanata Kitagawa, Akito Shibuya, Kozue Nakagomi, Tomohiro Ota, Yuri Anzo, Rika Miyauchi, Aiko Shono, Kazuhiro Watanabe, Katsuya Otori

Biological and Pharmaceutical Bulletin · 2024

DOI: 10.1248/bpb.b23-00819 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Hiroshi Inano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kitasato University Hospital. Hauptthemen laut MEDLINE: Antiemetics, Neoplasms, Antineoplastic Agents, Morpholines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntiemeticsNeoplasmsAntineoplastic AgentsMorpholinesHumansAprepitantCisplatinEmeticsRetrospective StudiesCase-Control StudiesVomitingNeurokinin-1 Receptor AntagonistsGastrointestinal Agents

Stichwörter der Autor:innen

aprepitantchemotherapy-induced nausea and vomitingdelayed emesisfosaprepitantfosnetupitantneurokinin 1 receptor antagonist

Substanzen

AprepitantCisplatinAntiemeticsfosaprepitantEmeticsNeurokinin-1 Receptor AntagonistsGastrointestinal AgentsAntineoplastic AgentsMorpholines

Autor:innen und Institutionen

  • Department of Pharmacy, Kitasato University Hospital.
  • Education and Research Center for Clinical Pharmacy, Showa Pharmaceutical University.
  • Laboratory of Social Pharmacy and Regulatory Science, Showa Pharmaceutical University.
  • Laboratory of Pharmacy Practice and Science I, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University.

Zitieren

APA

Inano, H., Morimoto, Y., Kitagawa, K., Shibuya, A., Nakagomi, K., Ota, T., Anzo, Y., Miyauchi, R., Shono, A., Watanabe, K., & Otori, K. (2024). Comparing the Efficacy of Fosnetupitant, an NK1 Receptor Antagonist in CDDP-Based Regimens, with That of Fosaprepitant and Aprepitant: A Retrospective Observational Study. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00819

Vancouver

Inano H, Morimoto Y, Kitagawa K, Shibuya A, Nakagomi K, Ota T, et al. Comparing the Efficacy of Fosnetupitant, an NK1 Receptor Antagonist in CDDP-Based Regimens, with That of Fosaprepitant and Aprepitant: A Retrospective Observational Study. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b23-00819

BibTeX
@article{Inano2024,
  author = {Inano, Hiroshi and Morimoto, Yoshihito and Kitagawa, Kanata and Shibuya, Akito and Nakagomi, Kozue and Ota, Tomohiro and Anzo, Yuri and Miyauchi, Rika and Shono, Aiko and Watanabe, Kazuhiro and Otori, Katsuya},
  title = {Comparing the Efficacy of Fosnetupitant, an NK1 Receptor Antagonist in CDDP-Based Regimens, with That of Fosaprepitant and Aprepitant: A Retrospective Observational Study},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2024},
  doi = {10.1248/bpb.b23-00819}
}
Kostenlos starten →